PROGINS Alu sequence insertion is associated with hyperprolactinaemia but not leiomyoma susceptibility

Clinical Endocrinology

Volumn 62, Issue 4, 2005, Pages 492-497

  Hsieh, Yao Yuan ^a,b   Chan, Ian Pan ^a   Wang, Hsin I ^a   Chang, Chi Chen ^b   Huang, Ching Wei ^a   Lin, Chich Sheng ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR;

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; ELECTROPHORESIS; FEMALE; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERPROLACTINEMIA; INTRON; LEIOMYOMA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PGR GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECEPTOR GENE;

ADULT; ALLELES; ALU ELEMENTS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERPROLACTINEMIA; LEIOMYOMA; POLYMORPHISM, GENETIC; RECEPTORS, PROGESTERONE; TAIWAN; UTERINE NEOPLASMS;

EID: 17044380849     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02251.x     Document Type: Article

References (61)

1. Cramer, D.W. (1992) Epidemiology of myomas. Seminars in Reproduction Endocrinology, 10, 320-324.
2. Mashal, R.D., Fejzo, M.L., Friedman, A.J., Milchner, N., Nowak, R.A., Rein, M.S., Morton, C.C. & Sklar, J. (1994) Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes, Chromosomes and Cancer, 11, 1-6.
3. Reeve, A.E., Eccles, M.R., Wilkins, R.J., Bell, G.I. & Millow, L.J. (1985) Expression of insulin-like growth factor-II transcripts in Wilms' tumour. Nature, 317, 258-260.
4. El-Badry, O.M., Helman, L.J., Chatten, J., Steinberg, S.M., Evans, A.E. & Israel, M.A. (1991) Insulin-like growth factor II-mediated proliferation of human neuroblastoma. Journal of Clinical Investigations, 87, 648-657.
5. Maruo, T., Ohara, N., Wang, J. & Matsuo, H. (2004) Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Human Reproduction Update, 10, 207-220.
6. Flake, G.P., Andersen, J. & Dixon, D. (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environmental Health Perspectives, 111, 1037-1054.
7. Soules, M.R. & McCarty, K.S. (1982) Leiomyomas steroid receptor content. American Journal of Obstetrics and Gynecology, 143, 6-11.
8. Massart, F., Becherini, L., Marini, F. et al. (2003) Analysis of estrogen receptor (ERα and ERβ) and progesterone receptor (PR) polymorphisms in uterine leiomyomas. Medical Science Monitor, 9, BR25-30.
9. Wu, X., Wang, H., Englund, K., Blanck, A., Lindblom, B. & Sahlin, L. (2002) Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue. Fertility and Sterility, 78, 985-993.
10. Williams, R.F., Gordon, K., Fung, H., Kolm, P. & Hodgen, G.D. (1994) Hypothalamo-pituitary effects of RU486: inhibition of progesterone-induced hyperprolactinaemia. Human Reproduction, 9, 63-68.
11. Smith, S., Wheeler, M.J., Murray, R. & O'Keane, V. (2002) The effects of antipsychotic-induced hyperprolactinaemia on the hypothalamic-pituitary- gonadal axis. Journal of Clinical Psychopharmacology, 22, 109-114.
12. Schmidt, P.J., Raju, J., Danaceau, M., Murphy, D.L. & Berlin, R.E. (2002) The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m-chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men. Neuropsychopharmacology, 27, 800-812.
13. Caron, R.W. & Deis, R.P. (1998) Estradiol implants in the arcuate nucleus induce lactogenesis in virgin rats: role of progesterone. Life Science, 62, 229-237.
14. Piroli, G.G., Grillo, C.A., Ferrini, M.G., Lux-Lantos, V. & De Nicola, A.F. (1996) Antagonism by progesterone of diethylstilbestrol-induced pituitary tumorigenesis in Fischer 344 rats: effects on sex steroid receptors and tyrosine hydroxylase mRNA. Neuroendocrinology, 63, 530-539.
15. Clark, G.M., McGuire, W.L., Hubay, C.A., Pearson, O.H. & Marshall, J.S. (1983) Progesterone receptors as a prognostic factor in stage II breast cancer. New England Journal of Medicine, 309, 1343-1347.
16. Slotman, B.J., Kuhnel, R., Rao, B.R., Dijkhuizen, G.H., de Graaff, J. & Stolk, J.G. (1989) Importance of steroid receptors and aromatase activity in the prognosis of ovarian cancer: high tumor progesterone receptor levels correlate with longer survival. Gynecological Oncology, 33, 76-81.
17. Rousseau-Merck, M.F., Misrahi, M., Loosfelt, H., Milgrom, E. & Berger, R. (1987) Localization of the human progesterone receptor gene to chromosome 11q22-q23. Human Genetics, 77, 280-282.
18. Rowe, S.M., Coughlan, S.J., McKenna, NJ. et al. (1995) Ovarian carcinoma-associated TaqI restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Research, 55, 2743-2745.
19. Ligon, A.H. & Morton, C.C. (2001) Leiomyomata: heritability and cytogenetic studies. Human Reproduction Update, 7, 8-14.
20. Limas, C.J., Kroupis, C., Haidaroglou, A. & Cokkinos, D.V. (2002) Hyperprolactinaemia in patients with heart failure: clinical and immunogenetic correlations. European Journal of Clinical Investigations, 32, 74-78.
21. Westberg, L., Ho, H.P., Baghaei, F., Nilsson, S., Melke, J., Rosmond, R., Holm, G., Bjorntorp, P. & Eriksson, E. (2004) Polymorphisms in oestrogen and progesterone receptor genes: possible influence on prolactin levels in women. Clinical Endocrinology, 61, 216-223.
22. Stevens, A., Ray, D.W., Worthington, J. & Davis, J.R. (2001) Polymorphisms of the human prolactin gene: implications for production of lymphocyte prolactin and systemic lupus erythematosus. Lupus, 10, 676-683.
23. Fujimoto, J., Hirose, R., Sakaguchi, H. & Tamaya, T. (2000) Expression of size-polymorphic androgen receptor gene in uterine leiomyoma according to the number of cytosine, adenine, and guanine repeats in androgen receptor alleles. Tumour Biology, 21, 33-37.
24. Kitawaki, J., Obayashi, H., Ishihara, H. et al. (2001) Oestrogen receptor-α gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata. Human Reproduction, 16, 51-55.
25. Hsieh, Y.Y., Chang, C.C., Tsai, F.J., Tsai, H.D., Yeh, L.S., Lin, C.C. & Tsai, C.H. (2003) Estrogen receptor thymine-adenine dinucleotide repeat polymorphism is associated with susceptibility to leiomyoma. Fertility and Sterility, 79, 96-99.
26. Rein, M.S. (2000) Advances in uterine leiomyoma research: the progesterone hypothesis. Environmental Health Perspectives, 108, 791-793.
27. Schweppe, K.W. (1999) Progestins and uterine leiomyoma. Gynecological Endocrinology, 13, 21-24.
28. Hodges, L.C., Houston, K.D., Hunter, D.S., Fuchs-Young, R., Zhang, Z., Wineker, R.C. & Walker, C.L. (2002) Transdominant suppression of estrogen receptor signaling by progesterone receptor ligands in uterine leiomyoma cells. Molecular Cell Endocrinology, 196, 11-20.
29. van de Yen, J., Sprong, M., Donker, G.H., Thijssen, J.H., Mak-Kregar, S. & Blankenstein, M.A. (2001) Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin-releasing hormone analogs. Gynecological Endocrinology, 15, 61-68.
30. Pecins-Thompson, M., Widmann, A.A. & Bethea, C.L. (1996) β-Endorphin, but not oxytocin, substance P or vasoactive-intestinal polypeptide, contributes to progesterone-induced prolactin secretion in monkeys. Neuroendocrinology, 63, 569-578.
31. Pecins-Thompson, M. & Bethea, C.L. (1997) RU486 blocks and fluoxetine augments progesterone-induced prolactin secretion in monkeys. Neuroendocrinology, 65, 335-343.
32. Tomogane, H., Mizoguchi, K. & Yokoyama, A. (1990) Effects of progesterone on concentrations of monoamines in hypothalamic areas and plasma prolactin levels in rats. Proceedings of the Society of Experimental Biological Medicine, 195, 208-212.
33. Tessier, C., Deb, S., Prigent-Tessier, A., Ferguson-Gottschall, S., Gibori, G.B., Shiu, R.P. & Gibori, G. (2000) Estrogen receptors alpha and beta in rat decidua cells: cell-specific expression and differential regulation by steroid hormones and prolactin. Endocrinology, 141, 3842-3851.
34. Brosens, J.J., Hayashi, N. & White, J.O. (1999) Progesterone receptor regulates decidual prolactin expression in differentiating human endometrial stromal cells. Endocrinology, 140, 4809-4820.
35. Hovey, R.C., Trott, J.F., Ginsburg, E., Goldhar, A., Sasaki, M.M., Fountain, S.J., Sundararajan, K. & Vonderhaar, B.K. (2001) Transcriptional and spatiotemporal regulation of prolactin receptor mRNA and cooperativity with progesterone receptor function during ductal branch growth in the mammary gland. Developmental Dynamics, 222, 192-205.
36. Taylor, K.M., Gray, C.A., Joyce, M.M., Stewart, M.D., Bazer, F.W. & Spencer, T.E. (2000) Neonatal ovine uterine development involves alterations in expression of receptors for estrogen, progesterone, and prolactin. Biological Reproduction, 63, 1192-1204.
37. Andersen, T.I., Heimdal, K.R., Skrede, M., Tveit, K., Berg, K. & Borresen, A.L. (1994) Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Human Genetics, 94, 665-670.
38. Jiang, X., Hitchcock, A., Bryan, E.J. et al. (1996) Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Research, 56, 3534-3539.
39. Fabjani, G., Tong, D., Czerwenka, K., Schuster, E., Speiser, P., Leodolter, S. & Zeillinger, R. (2002) Human progesterone receptor gene polymorphism PROGINS and risk for breast cancer in Austrian women. Breast Cancer Research and Treatment, 72, 131-137.
40. Kieback, D.G., Tong, X.W., Wiegel, N.L. & Agoulnick, I.U. (1998) A genetic mutation in the progesterone receptor (PROGINS) leads to an increased risk of nonfamilial breast and ovarian cancer causing inadequate control of estrogen receptor driven proliferation. Gynecological Investigations, 5, 40a.
41. Wieser, F., Schneeberger, C., Tong, D., Tempfer, C, Huber, J.C. & Wenzl, R. (2002) PROGINS receptor gene polymorphism is associated with endometriosis. Fertility and Sterility, 77, 309-312.
42. Wang-Gohrke, S., Chang-Claude, J., Becher, H., Kieback, D.G. & Runnebaum, I.B. (2000) Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50. Cancer Research, 60, 2348-2350.
43. Mihara, K., Kondo, T., Suzuki, A., Yasui, N., Nagashima, U., Ono, S., Otani, K. & Kaneko, S. (2000) Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene. Psychopharmacology, 149, 246-250.
44. Lattuada, D., Somigliana, E., Vigano, P., Candiani, M., Pardi, G. & Di Blasio, A.M. (2004) Genetics of endometriosis: a role for the progesterone receptor gene polymorphism PROGINS? Clinical Endocrinology, 61, 190-194.
45. De Vivo, I., Hankinson, S.E., Colditz, G.A. & Hunter, D.J. (2003) A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk. Cancer Research, 63, 5236-5238.
46. Cramer, D.W., Hornstein, M.D., McShane, P., Powers, R.D., Lescault, P.J., Vitonis, A.F. & De Vivo, I. (2003) Human progesterone receptor polymorphisms and implantation failure during in vitro fertilization. American Journal of Obstetrics and Gynecology, 189, 1085-1092.
47. Shintani, S., Matsuo, K., Crohin, C.C., McBride, J., Tsuji, T., Donoff, R.B., Posner, M., Todd, R. & Wong, D.T. (1999) Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Research, 59, 4142-4147.
48. Kennon, B., Ingram, M.C., Friel, E.C. et al. (2004) Aldosterone synthase gene variation and adrenocortical response to sodium status, angiotensin II and ACTH in normal male subjects. Clinical Endocrinology, 61, 174-181.
49. Shirasawa, S., Harada, H., Furugaki, K. et al. (2004) SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Human Molecular Genetics, August 4.
50. Engehausen, D.G. & Schrott, K.M. (2000) PROGINS polymorphism of progesterone receptor is increased in female offspring with maternal exposure to diethylstilbestrol. Anticancer Research, 20, 5145-5149.
51. Wasserman, L., Flatt, S.W., Natarajan, L. et al. (2004) Correlates of obesity in postmenopausal women with breast cancer: comparison of genetic, demographic, disease-related, life history and dietary factors. International Journal of Obesity and Related Metabolism Disorders, 28, 49-56.
52. Modugno, F. (2004) Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review. American Journal of Epidemiology, 159, 319-335.
53. Tong, D., Fabjani, G., Heinze, G., Obermair, A., Leodolter, S. & Zeillinger, R. (2001) Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. International Journal of Cancer, 95, 394-397.
54. Ho, H.P., Westberg, L., Annerbrink, K. et al. (2004) Association between a functional polymorphism in the progesterone receptor gene and panic disorder in women. Psychoneuroendocrinology, 29, 1138-1141.
55. Donaldson, C.J., Crapanzano, J.P., Watson, J.C., Levine, E.A. & Batzer, M.A. (2002) PROGINS Alu insertion and human genomic diversity. Mutation Research, 501, 137-141.
56. Kurz, C., Tempfer, C.B., Boecskoer, S., Unfried, G., Nagele, F. & Hefler, L.A. (2001) The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. Journal of Society of Gynecological Investigations, 8, 295-298.
57. De Vivo, I., Huggins, G.S., Hankinson, S.E., Lescault, P.J., Boezen, M., Colditz, G.A. & Hunter, D.J. (2002) A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proceedings of the National Academy of Sciences of the USA, 99, 12263-12268.
58. Feigelson, H.S., Rodriguez, C., Jacobs, E.J., Diver, W.R., Thun, M.J. & Calle, E.E. (2004) No association between the progesterone receptor gene +331G/A polymorphism and breast cancer. Cancer Epidemiology, Biomarkers and Prevention, 13, 1084-1085.
59. Schweikert, A., Rau, T., Berkholz, A., Allera, A., Daufeldt, S. & Wildt, L. (2004) Association of progesterone receptor polymorphism with recurrent abortions. European Journal of Obstetrics and Gynecological Reproduction Biology, 113, 67-72.
60. Spurdle, A.B., Hopper, J.L., Chen, X., McCredie, M.R., Giles, G.G., Venter, D.J., Southey, M.C. & Chenevix-Trench, G. (2002) The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. Cancer Epidemiology, Biomarkers and Prevention, 11, 439-443.
61. Spurdle, A.B., Webb, P.M., Purdie, D.M., Chen, X., Green, A. & Chenevix-Trench, G. (2001) No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. Carcinogenesis, 22, 717-721.